يعرض 401 - 420 نتائج من 1,774 نتيجة بحث عن '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 10 ((steel decrease) OR (a decrease)) ))', وقت الاستعلام: 0.19s تنقيح النتائج
  1. 401
  2. 402
  3. 403
  4. 404
  5. 405
  6. 406
  7. 407
  8. 408
  9. 409
  10. 410
  11. 411
  12. 412
  13. 413
  14. 414
  15. 415

    Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study حسب Rajesh, Sharma

    منشور في 2024
    "…FindingsAll cancers combined claimed an estimated 5.6 million [95% uncertainty interval, 5.1–6.0 million] lives in Asia with 9.4 million [8.6–10.2 million] incident cases and 144.7 million [132.7–156.5 million] DALYs in 2019. …"
    احصل على النص الكامل
    احصل على النص الكامل
    احصل على النص الكامل
    article
  16. 416

    In vitro evaluation of Neosetophomone B inducing apoptosis in cutaneous T cell lymphoma by targeting the FOXM1 signaling pathway حسب Kuttikrishnan, Shilpa

    منشور في 2023
    "…Objective: In this study, we investigated the anti-cancer potential of Neosetophomone B (NSP-B), a fungal-derived secondary metabolite, on CTCL cell lines H9 and HH. …"
    احصل على النص الكامل
    احصل على النص الكامل
  17. 417
  18. 418
  19. 419
  20. 420

    Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 حسب Stein Emil, Vollset

    منشور في 2024
    "…The largest shift of this kind was forecasted for sub-Saharan Africa, from 20·1% (15·6–25·3) of DALYs due to YLDs in 2022 to 35·6% (26·5–43·0) in 2050. In the assessment of alternative future scenarios, the combined effects of the scenarios (Safer Environment, Improved Childhood Nutrition and Vaccination, and Improved Behavioural and Metabolic Risks scenarios) demonstrated an important decrease in the global burden of DALYs in 2050 of 15·4% (13·5–17·5) compared with the reference scenario, with decreases across super-regions ranging from 10·4% (9·7–11·3) in the high-income super-region to 23·9% (20·7–27·3) in north Africa and the Middle East. …"
    احصل على النص الكامل
    احصل على النص الكامل
    احصل على النص الكامل